Episode 3 of Pituitary Grand Rounds explores cortisol disorders tied to adrenal issues and diagnostic challenges.
There is an urgent world need for people with DI/Vasopressin Deficiency to understand and better manage this condition. The advocacy community, including the World Alliance of Pituitary Organizations – WAPO, the Got DI/AVP patient community,
Thanks to the lovely algorithms social media is using, we may only reach some of you with some posts, so here are a few of our latest articles and podcasts. We always encourage you to
From J D Faccinetti, Co-founder and Chief Editor – When you deal with a chronic pituitary disease, you get close to your medications, just like you would to a friend. This was my experience with
UCSF Neurosurgeon Dr. Manish Aghi, MD, Ph.D. Professor of Neurological Surgery UCSF Weill Institute for Neurosciences presents “Endoscopic surgery for sellar and parasellar tumors – Lessons learned in the OR and laboratory.”
San Diego, California-based Crinetics Pharmaceutical announced today that its novel investigational drug paltusotine maintained IGf-1 levels in patients who switched from monthly injectables
In a recent JAMA Network article covering the COVID-19 pandemic, 23.3% of physicians reported personal attacks on social media. Online bullying and social media harassment are nothing new, but this behavior, plus considerable misinformation, makes disseminating helpful, accurate content an ongoing challenge.
On February 28, many organizations that advocate for cures, therapies, drugs, and critically early diagnosis for the known 7000 plus rare diseases join forces to focus on rare diseases. We support rarediseaseday.org and the many
From Jorge D. Faccinetti – co-founder. With a pituitary disease like acromegaly, Cushing’s, hypopituitarism, and others, or for that matter, any other chronic condition, a big part of the battle is to get up every
A presentation from Lewis Blevins, M.D. Pituitary World News cofounder and Medical Director of the California Center for Pituitary Disorders at UCSF on the emerging clinical insights of hypercortisolism. Click here to view the presentation.
Not surprisingly, COVID-19 appears to have significantly impacted pituitary patients’ access to healthcare. Our brief survey elicited information from respondents on their experiences and attitudes towards obtaining healthcare via telemedicine. Dr. Blevins shares the findings